Yubo International Biotech Limited
YBGJ
$0.01
$0.005.26%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 12.40K | 0.00 | 0.00 | 0.00 | 3.50K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 12.40K | 0.00 | 0.00 | 0.00 | 3.50K |
| Cost of Revenue | 4.20K | -4.30K | 84.00K | 211.90K | 212.70K |
| Gross Profit | 8.20K | 4.30K | -84.00K | -211.90K | -209.20K |
| SG&A Expenses | 1.01M | 1.14M | 1.29M | 1.35M | 1.25M |
| Depreciation & Amortization | 177.70K | 175.70K | 181.70K | 181.40K | 183.30K |
| Other Operating Expenses | 135.30K | 70.60K | 131.20K | 298.70K | 341.70K |
| Total Operating Expenses | 1.32M | 1.38M | 1.69M | 2.04M | 1.99M |
| Operating Income | -1.31M | -1.38M | -1.69M | -2.04M | -1.98M |
| Income Before Tax | -1.31M | -1.38M | -1.69M | -2.04M | -1.98M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.31 | -1.38 | -1.69 | -2.04 | -1.98 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 108.70K | 147.70K | 154.50K | 205.90K | 206.40K |
| Net Income | -1.20M | -1.23M | -1.54M | -1.83M | -1.78M |
| EBIT | -1.31M | -1.38M | -1.69M | -2.04M | -1.98M |
| EBITDA | -1.13M | -1.20M | -1.51M | -1.86M | -1.80M |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.02 | -0.04 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.03 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.02 | -0.04 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.03 |
| Average Basic Shares Outstanding | 558.27M | 507.33M | 479.28M | 479.28M | 371.44M |
| Average Diluted Shares Outstanding | 558.27M | 507.33M | 479.28M | 479.28M | 371.44M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |